You are here


Journal Name:

Publication Year:

Author Name
Abstract (2. Language): 
Introduction: The deliberate inhalation of volatile substance can cause serious harm to psychological, emotional and neurobiological development. Inhalants are considered to be harmful substance used as it is linked with high rate of morbidity. Lack of knowledge, expertise in the field of inhalant dependence, resulted in little research about the subject. Current research is focused on evaluation of the symptomatology of inhalant intoxication and withdrawal. Methods: This is a prospective cross-sectional study of inhalant users in 32 cases meeting criteria for inhalant abuse according to DSM-IV-TR in a tertiary-level multi-specialty hospital. Results and conclusion: The most common inhalant used was whitener and most common method was sniffing. Among all intoxication symptoms, euphoria was most common (97%) followed by hallucinations (88%), burning in oropharynx (69%), light headedness (47%), drowsiness (38%) etc. Common withdrawal features reported were: craving (97%), irritability (94%), restlessness (88%), insomnia (78%) etc.



1. American Psychiatric Association.
Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition. Washington, D.C:
American Psychiatric Press. 2000;257-263
2. Kurtzman TL, Otsuka KN, Wahl RA.
Inhalant abuse by adolescents. J Adolesc
Health.2001; 28: 170–180.
3. Bowen SE. Increases in amphetamine-like
discriminative stimulus effects of the abused
inhalant toluene in mice.
Psychopharmacology (Berl).2006; 186: 517–
4. Balster RL, Cruz SL, Howard MO, et al.
Classification of abused inhalants. Addiction.
2009; 104(6):878–82.
5. Balster RL. Neural basis of inhalant abuse.
Drug Alcohol Depend.1998; 51: 207–14.
6. Dinwiddie SH. Abuse of inhalants: a review.
Addiction. 1994; 89(8):925–39.
7. Dinwiddie SH. Psychological and psychiatric
consequences of inhalants. In: Tarter, RE.;
Ammerman RT, Ott PJ. editors. Handbook of
Substance Abuse: Neurobehavioral
Pharmacology.New York: Plenum; 1998.
8. Shah R, Vankar GK, Upadhyaya HP.
Phenomenology of gasoline intoxication and
withdrawal symptoms among adolescents in
India: A case series. Am J Addict
9. Kumar S, Grover S, Kulhara P, Mattoo SK,
Basu D, Biswas P, et al. Inhalant abuse: a
clinic-based study. Indian J Psychiatry
10. Seth R, Kotwal A, Ganguly KK. Street and
working children of Delhi, India, misusing
toluene: an ethnographic exploration. Subst
Use Misuse 2005;40:1659-79.
11. D’Abbs P, MacLean S. Volatile substance
misuse: A review of interventions. National
Drug Strategy, Monograph Series No. 65.
Australian Government, Department of
Health and Aging.2008.
12. Howard MO et al. Inhalant use among
incarcerated adolescents in the United States:
Prevalence, characteristics, and correlates of
use. Drug and Alcohol Dependence, 2008;
13. Bowen SE, Batis JC, Paez-Martinez N, Cruz
SL. The last decade of solvent research in
animal models of abuse: mechanistic and
behavioral studies. Neurotoxicol Teratol,
2006; 28: 636–647.
14. Giannini AJ. The volatile agents. In: Miller
NS, ed. Comprehensive Handbook of Drug
and Alcohol Addiction. New York, NY:
Marcel Dekker; 1991: 125–130.
15. Jaffe JH. Drug addiction and drug abuse. In:
Gilman AG, Rall TW, Nies TW, Taylor P,
eds. The Pharmacological Basis of
Therapeutics. 8th ed. New York, NY:
McGraw-Hill; 1990:522–573.
16. Brady M. In: Heavy Metal: The Social
Meaning of Petrol Sniffing in Australia.
Canberra: Aboriginal Studies Press; 1992.
17. National Institute of Drug Abuse. Research
report series: Inhalant Abuse. NIH
Publication Number 05-3818, Revised March
18. Pahwa M, Baweja A, Gupta V, Jiloha RC.
Petrol-inhalation dependence: A case report.
Indian J Psychiatry 1998;40:92-4.
19. Waraich BK, Chavan BS, Raj L. Inhalant
abuse: A growing public health concern in
India. Addiction 2003;98:1169.
20. Basu D, Jhirwal OP, Singh J, Kumar S,
Mattoo SK. Inhalant abuse by adolescents: A
new challenge for Indian physicians. Indian J
Med Sci 2004;58:245-9.
21. Das PS, Sharan P, Saxena S. Kerosene abuse
by inhalation and ingestion. Am J Psychiatry
22. Howard M, Bowen S, Garland E, Perron B,
Vaughn M. Inhalant Use and Inhalant Use
Disorders in the United States. Addiction
Science and Clinical Practice 2011; 07:18-31

Thank you for copying data from